Kinematic improvement following Botulinum Toxin-A injection in upper-limb spasticity due to stroke.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 19965856.
- Also identified by DOI 10.1136/jnnp.2009.188052 and PMC identifier 3163597.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Background Focal spasticity is a significant motor disorder following stroke, and Botulinum Toxin Type-A (BoNT-A) is a useful treatment for this. The authors evaluated kinematic modifications induced by spasticity, and whether or not there is any improvement following injection of BoNT-A. Methods Eight patients with stroke with upper-limb spasticity, showing a flexor pattern, were evaluated using kinematics before and after focal treatment with BoNT-A. A group of sex- and age-matched normal volunteers acted as a control group. Results Repeated-measures ANOVA showed that patients with stroke performed more slowly than the control group. Following treatment with BoNT-A, there was a significant improvement in kinematics in patients with stroke, while in the control group, performance remained unchanged. Conclusions Focal treatment of spasticity with BoNT-A leads to an adaptive change in the upper limb of patients with spastic stroke.
Medical subject headings
- Biomechanical Phenomena
- Botulinum Toxins, Type A
- Neuromuscular Agents
- Spasm
- Stroke
- Upper Extremity